DE220574T1 - Menschliches interferon-beta2a und interferon-beta2b - Google Patents

Menschliches interferon-beta2a und interferon-beta2b

Info

Publication number
DE220574T1
DE220574T1 DE198686114049T DE86114049T DE220574T1 DE 220574 T1 DE220574 T1 DE 220574T1 DE 198686114049 T DE198686114049 T DE 198686114049T DE 86114049 T DE86114049 T DE 86114049T DE 220574 T1 DE220574 T1 DE 220574T1
Authority
DE
Germany
Prior art keywords
interferon
beta2b
beta2a
human
human interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198686114049T
Other languages
English (en)
Inventor
Michel Revel
Asher Rehovot Il Zilberstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26321482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE220574(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL76714A external-priority patent/IL76714A0/xx
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE220574T1 publication Critical patent/DE220574T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE198686114049T 1985-10-14 1986-10-10 Menschliches interferon-beta2a und interferon-beta2b Pending DE220574T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL76714A IL76714A0 (en) 1985-10-14 1985-10-14 Recombined human interferon beta-2 and a method of producing same
US86088386A 1986-05-08 1986-05-08

Publications (1)

Publication Number Publication Date
DE220574T1 true DE220574T1 (de) 1987-11-26

Family

ID=26321482

Family Applications (4)

Application Number Title Priority Date Filing Date
DE198686114049T Pending DE220574T1 (de) 1985-10-14 1986-10-10 Menschliches interferon-beta2a und interferon-beta2b
DE3650790T Expired - Lifetime DE3650790T2 (de) 1985-10-14 1986-10-10 Menschlisches Interferon-Beta 2A zur Verwendung als Arzneimittel
DE3688671T Expired - Lifetime DE3688671T3 (de) 1985-10-14 1986-10-10 Menschliches Interferon-beta2A ; Vektoren, die Gene enthalten, die für das genannte Interferon kodieren; Zellinien, die dieses produzieren und Verwendung des genannten Interferons als Pharmazeutikum.
DE3650715T Expired - Lifetime DE3650715T2 (de) 1985-10-14 1986-10-10 Verwendung von menschlichem Interferon-Beta 2A für die Herstellung von Medikamenten

Family Applications After (3)

Application Number Title Priority Date Filing Date
DE3650790T Expired - Lifetime DE3650790T2 (de) 1985-10-14 1986-10-10 Menschlisches Interferon-Beta 2A zur Verwendung als Arzneimittel
DE3688671T Expired - Lifetime DE3688671T3 (de) 1985-10-14 1986-10-10 Menschliches Interferon-beta2A ; Vektoren, die Gene enthalten, die für das genannte Interferon kodieren; Zellinien, die dieses produzieren und Verwendung des genannten Interferons als Pharmazeutikum.
DE3650715T Expired - Lifetime DE3650715T2 (de) 1985-10-14 1986-10-10 Verwendung von menschlichem Interferon-Beta 2A für die Herstellung von Medikamenten

Country Status (6)

Country Link
EP (4) EP0536520B1 (de)
AU (1) AU602872B2 (de)
CA (1) CA1341369C (de)
DE (4) DE220574T1 (de)
ES (2) ES2058053T5 (de)
GR (2) GR3030150T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
US6284237B1 (en) 1986-07-08 2001-09-04 Steven C. Clark Methods of treatment using IL-6
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor
US4973478A (en) * 1987-07-20 1990-11-27 Allelix Biopharmaceuticals, Inc. Treating inflammation with hepatocyte stimulating factor interferon β2
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL85204A0 (en) * 1988-01-26 1988-07-31 Yeda Res & Dev Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
US5641868A (en) * 1991-04-18 1997-06-24 Toray Industries, Inc. Interlekin-6 compositions, and a production process thereof
IT1254359B (it) * 1992-05-11 1995-09-14 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti il-6
US5902576A (en) * 1992-10-22 1999-05-11 Yeda Research And Development Co. Ltd. At Weizmann Institute Of Science Antitumor pharmaceutical composition comprising IL-6 transfected cells
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
IL147414A0 (en) 2001-12-31 2002-08-14 Yeda Res & Dev Ifnar2 mutants, their production and use
WO2004019886A2 (en) 2002-08-29 2004-03-11 Cytocure Llc Methods for up-regulating antigen expression in tumors
EP1608400B1 (de) * 2003-03-28 2010-06-23 Faron Pharmaceuticals OY Erhöhung des adenosin-spiegels durch cytokin-induzierte expression von cd73
CN108004270B (zh) * 2017-11-24 2021-06-18 上海交通大学 利用双荧光素酶报告基因检测鸭IFN-β启动子活性的方法
CN112442504B (zh) * 2020-12-10 2023-01-24 电子科技大学 一种重组草鱼白介素-12活性蛋白的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
JPS60169424A (ja) * 1984-02-15 1985-09-02 Chuzo Kishimoto 新規ヒトｂ細胞分化因子，その製造法およびその使用法
JPS61246197A (ja) * 1985-04-24 1986-11-01 Ajinomoto Co Inc Ｄｎａ
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0257406B2 (de) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor

Also Published As

Publication number Publication date
GR3033769T3 (en) 2000-10-31
DE3650715T2 (de) 1999-06-24
EP0645452A1 (de) 1995-03-29
DE3688671D1 (de) 1993-08-12
EP0835661A3 (de) 1998-05-20
EP0536520A1 (de) 1993-04-14
CA1341369C (en) 2002-06-18
ES2058053T5 (es) 2000-11-01
DE3688671T3 (de) 2001-05-03
DE3650790D1 (de) 2007-10-11
EP0220574B2 (de) 2000-04-12
EP0220574B1 (de) 1993-07-07
ES2131513T3 (es) 1999-08-01
DE3650790T2 (de) 2008-01-24
AU6386786A (en) 1987-04-16
EP0220574A1 (de) 1987-05-06
GR3030150T3 (en) 1999-08-31
ES2058053T3 (es) 1994-11-01
DE3688671T2 (de) 1993-10-14
EP0835661B1 (de) 2007-08-29
EP0536520B1 (de) 1999-03-03
DE3650715D1 (de) 1999-04-08
EP0835661A2 (de) 1998-04-15
AU602872B2 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
ATA334586A (de) Mehrfach unterteilte transdermale und dermale pflaster
DE3669997D1 (de) Rollstuhl und anwendungsweise.
DK441586D0 (da) Kirurgisk indretning
ES292142Y (es) Dispositivo de montaje de protesis oseas y similares
DK161007C (da) Hospitalsseng
BR8604388A (pt) Artigo absorvente e absorvente higienico
DK551187A (da) Terapeutisk praeparat og dettes fremstilling
DK359686D0 (da) Lyofiliserede emulsionsmidler og fremgangsmaade
DK543386A (da) Thienooxazinoner deres fremstilling og anvendelse
DK190786D0 (da) Antioxidationsmiddel og hudplejemiddel indeholdende samme samt anvendelse heraf
EP0204659A3 (en) Polyepoxydes and their use
DK412787D0 (da) Medicinsk-kirurgisk pose og dennes fremstilling
DE220574T1 (de) Menschliches interferon-beta2a und interferon-beta2b
DK254488D0 (da) Azaindol- og indolizinderivater
DE3679764D1 (de) Zaepfchen und grundlage dafuer.
DK232386A (da) Fraebehandling
DK139286D0 (da) Inden- og naphthalenderivater
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
DK456686D0 (da) Stabiliseret human prourokinase
DK406086A (da) Bbm-1675c og d-antitumor-antibiotica
PT81848A (de) Synergistische kombination von flupirtin und 4-acetamido-phenol
ES551181A0 (es) Procedimiento y dispositivo de tomodensitometria cuantitativa
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
DK363786A (da) Hydroquinoliner og anvendelse deraf